Cargando…
Treatment of Severe Hypercapnic Respiratory Failure Caused by SARS-CoV-2 Lung Injury with ECCO(2)R Using the Hemolung Respiratory Assist System
Acute respiratory distress syndrome (ARDS) due to COVID-19 leads to a high rate of mortality in the intensive care unit (ICU). A lung-protective mechanical ventilation strategy using low tidal volumes is a cornerstone to management, but uncontrolled hypercapnia is a life-threatening consequence amon...
Autores principales: | Saavedra-Romero, Ramiro, Paz, Francisco, Litell, John M., Weinkauf, Julia, Benson, Carina C., Tindell, Lisa, Williams, Kari |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8245249/ https://www.ncbi.nlm.nih.gov/pubmed/34327027 http://dx.doi.org/10.1155/2021/9958343 |
Ejemplares similares
-
Physiologic Improvement in Respiratory Acidosis Using Extracorporeal Co(2) Removal With Hemolung Respiratory Assist System in the Management of Severe Respiratory Failure From Coronavirus Disease 2019
por: Akkanti, Bindu, et al.
Publicado: (2021) -
Extracorporeal carbon dioxide removal (ECCO2R) in COPD and ARDS patients with severe hypercapnic respiratory failure. A retrospective case-control study
por: İNAL, Volkan, et al.
Publicado: (2021) -
Coagulation Disorders in Subjects Undergoing Pump-Driven Veno-Venous Ecco2-R For Severe Acute Hypercapnic Respiratory Failure - a Single Center Experience
por: Harler, U, et al.
Publicado: (2015) -
Asthma and hypercapnic respiratory failure
por: Shamil, P.K., et al.
Publicado: (2020) -
Pneumonia and hypercapnic respiratory failure
por: Ancans, Gusts, et al.
Publicado: (2019)